Status: Not yet recruiting
ESCUDDO Long Term Follow Up
This study evaluates the long term protection provided by either one or two doses of the 9vHPV vaccine for participants who were part of the ESCUDDO study.
Participants needed: 9,700
Trial details
Age: 18+Biological sex: FemaleType: ObservationalSponsor: National Cancer Institute (NCI)Updated: Aug 20, 2026Locations: 1
Eligibility criteria
* Participation in ESCUDDO base study [+4]
* Enrollment cannot occur beyond her 10 year study visit [+4]